Invention Grant
- Patent Title: Treatment of disease with esters of selective RXR agonists
-
Application No.: US16137167Application Date: 2018-09-20
-
Publication No.: US11517549B2Publication Date: 2022-12-06
- Inventor: Roshantha A. Chandraratna , Martin E. Sanders
- Applicant: Io Therapeutics, Inc.
- Applicant Address: US CA Santa Ana
- Assignee: Io Therapeutics, Inc.
- Current Assignee: Io Therapeutics, Inc.
- Current Assignee Address: US CA Santa Ana
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61P35/00 ; A61P25/16 ; A61P25/28 ; A61P21/00 ; A61K45/06 ; A61P37/02 ; A61K31/198 ; A61K9/00
Abstract:
The present specification provides methods of treating disease with an ester of an RXR agonist or a combination of an ester of an RXR agonist and a thyroid hormone. The esters of an RXR agonist can be useful in the treatment of cancer, nervous system, autoimmune, and muscular disorders.
Public/Granted literature
- US20190083441A1 TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS Public/Granted day:2019-03-21
Information query
